Literature DB >> 26703372

Association Between Tobacco Use, Symptom Expression, and Alcohol and Illicit Drug Use in Advanced Cancer Patients.

Yu Jung Kim1, Rony Dev2, Akhila Reddy3, David Hui3, Kimberson Tanco3, Minjeong Park4, Diane Liu4, Janet Williams3, Eduardo Bruera3.   

Abstract

CONTEXT: Limited knowledge exists examining the association between smoking status, symptom expression, and alcohol or illicit drug use.
OBJECTIVES: The goal of this study was to clarify these associations in patients with advanced cancer.
METHODS: We retrospectively reviewed 560 charts and identified 300 consecutive advanced cancer patients who completed a comprehensive smoking questionnaire. Data including the Edmonton Symptom Assessment System, Cut down/Annoyed/Guilty/Eye opener (CAGE) alcoholism screening questionnaire, illicit drug use history, and daily opioid requirements-morphine equivalent daily dose-were collected.
RESULTS: Among 300 patients, 119 (40%) were never smokers, 148 (49%) former smokers, and 33 (11%) current smokers. The most common malignancies were gastrointestinal (28%) and lung (20%). Current smokers were more likely to be single (P < 0.01) and significantly younger than former smokers (P < 0.001) but did not differ in age from never smokers. Never smokers were more likely to be female (P < 0.001). Current smokers reported significantly higher pain expression than former and never smokers (median 7 vs. 5.5 vs. 5, respectively, P = 0.02), higher CAGE positivity (42% vs. 21% vs. 3%, P < 0.001) and were more likely to have a history of illicit drug use (33% vs. 16% vs. 3%, P < 0.001). The morphine equivalent daily dose was not significantly different according to smoking status.
CONCLUSION: In advanced cancer, patients who were former or current smokers were significantly more likely to have a history of CAGE positivity and illicit drug use compared with never smokers. Current smokers expressed significantly higher pain. A smoking history may be a marker of an increased risk of opioid misuse. Published by Elsevier Inc.

Entities:  

Keywords:  Advanced cancer; alcoholism; cancer pain; chemical coping; opioid; symptom; tobacco use

Mesh:

Substances:

Year:  2015        PMID: 26703372     DOI: 10.1016/j.jpainsymman.2015.11.012

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  15 in total

Review 1.  Lifestyle Medicine Interventions in Patients With Advanced Disease Receiving Palliative or Hospice Care.

Authors:  Gowri Anandarajah; Haran Asher Mennillo; Gregory Rachu; Tyler Harder; Jyotsna Ghosh
Journal:  Am J Lifestyle Med       Date:  2019-02-15

Review 2.  The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments.

Authors:  David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2016-12-29       Impact factor: 3.612

3.  The effects of alcoholism and smoking on advanced cancer patients admitted to an acute supportive/palliative care unit.

Authors:  Sebastiano Mercadante; Claudio Adile; Patrizia Ferrera; Alessandra Casuccio
Journal:  Support Care Cancer       Date:  2017-02-16       Impact factor: 3.603

Review 4.  Pain in Cancer Survivors: How to Manage.

Authors:  Judith A Paice
Journal:  Curr Treat Options Oncol       Date:  2019-05-06

Review 5.  Management of Physical Symptoms in Patients with Advanced Cancer during the Last Weeks and Days of Life.

Authors:  Ahsan Azhar; David Hui
Journal:  Cancer Res Treat       Date:  2022-06-30       Impact factor: 5.036

6.  Pilot randomized controlled trial of a comprehensive smoking cessation intervention for patients with upper aerodigestive cancer undergoing radiotherapy.

Authors:  Eleni M Rettig; Carole Fakhry; Russell K Hales; Flora Kisuule; Harry Quon; Ana P Kiess; Linda X Yin; Yuehan Zhang; Amanda L Blackford; M Bradley Drummond; Christine G Gourin; Wayne M Koch; David W Eisele; Gypsyamber D'Souza
Journal:  Head Neck       Date:  2018-03-15       Impact factor: 3.147

7.  Response to Oral Immediate-Release Opioids for Breakthrough Pain in Patients with Advanced Cancer with Adequately Controlled Background Pain.

Authors:  Ahsan Azhar; Yu Jung Kim; Ali Haider; David Hui; Vishidha R Balankari; Margeaux Chiou Epner; Minjeong Park; Diane D Liu; Janet Williams; Susan E Frisbee-Hume; Julio A Allo; Eduardo Bruera
Journal:  Oncologist       Date:  2018-09-25

8.  Compliance with Opioid Therapy: Distinguishing Clinical Characteristics and Demographics Among Patients with Cancer Pain.

Authors:  Dhanalakshmi Koyyalagunta; Eduardo Bruera; Mitchell P Engle; Larry Driver; Wenli Dong; Chris Demaree; Diane M Novy
Journal:  Pain Med       Date:  2018-07-01       Impact factor: 3.750

Review 9.  Pancreas Cancer-Associated Pain Management.

Authors:  Andrew L Coveler; Jonathan Mizrahi; Bory Eastman; Smith Jim Apisarnthanarax; Shalini Dalal; Terry McNearney; Shubham Pant
Journal:  Oncologist       Date:  2021-05-12

10.  Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy.

Authors:  Kea Turner; Naomi C Brownstein; Zachary Thompson; Issam El Naqa; Yi Luo; Heather S L Jim; Dana E Rollison; Rachel Howard; Desmond Zeng; Stephen A Rosenberg; Bradford Perez; Andreas Saltos; Laura B Oswald; Brian D Gonzalez; Jessica Y Islam; Amir Alishahi Tabriz; Wenbin Zhang; Thomas J Dilling
Journal:  Radiother Oncol       Date:  2021-12-23       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.